BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Aryl hydrocarbon receptor (AHR)

June 25, 2015 7:00 AM UTC

In vitro and mouse studies suggest an endogenous AHR ligand could help treat cancer. In human glioblastoma cell lines, the endogenous tryptophan-based AHR ligand (1H-indole-3-carbonyl)-thiazole-4-carb...